Sort   by:  
 Page size 
Chelocardin is an atypical tetracycline and its mechanism of action is discussed controversially in literature. Therefore, we analyzed the bacterial response of Bacillus subtilis to chelocardin and as a control for classical tetracyclines to tetracycline by proteomic profiling. The induced marker pr...
ORGANISM(S): Bacillus subtilis subsp. subtilis str. 168 
2016-03-14 | PXD003439 | Pride
Identification of the molecular target is crucial for evaluating novel antibiotics. To support target identification, a label-free method based on chromatographic co-elution (TICC) has been developed previously. In TICC, an alteration in the elution profile of the target-bound drug compared to free ...
ORGANISM(S): Bacillus subtilis subsp. subtilis str. 168 
2020-10-01 | PXD017640 | Pride
The diazotrophic bacterium Rhodobacter capsulatus synthesizes a molybdenum nitrogenase and an alternative iron-only nitrogenase, enabling growth with molecular dinitrogen as sole nitrogen source. Regulation of nitrogen fixation was analyzed by proteome profiling of wild-type and mutant strains lacki...
ORGANISM(S): Rhodobacter capsulatus (strain ATCC BAA-309 / NBRC 16581 / SB1003) 
2019-07-19 | PXD013515 | Pride
Circumventing or overwhelming the bacterial adaptation capabilities is key to combatting multidrug-resistant pathogens like Pseudomonas aeruginosa. We investigated the physiological stress exerted by approved antibiotics (ciprofloxacin, levofloxacin, rifampicin, gentamicin, tobramycin, azithromycin,...
ORGANISM(S): Pseudomonas aeruginosa PAO1 
2022-08-12 | PXD022879 | Pride
The diazotrophic bacterium Rhodobacter capsulatus is able to synthesize two nitrogenases, a molybdenum-dependent and an alternative Mo-free iron-only nitrogenase, enabling growth with molecular dinitrogen (N2) as sole nitrogen source. The Mo response of the wild type and a mutant lacking the high-af...
ORGANISM(S): Rhodobacter capsulatus (strain ATCC BAA-309 / NBRC 16581 / SB1003) 
2015-12-14 | PXD003123 | Pride
Sort   by:  
 Page size